Target intelligence / Profile preview

Ghrelin antisense RNA 1 (non-protein coding) (GHRLOS)

Target
GHRLOS
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript, Non-protein coding RNA, Other (regulatory RNA)
01

Overview

GHRLOS is a long non-coding RNA (lncRNA) gene that is transcribed antisense to the ghrelin gene (GHRL) on chromosome 3p25.3[1][2]. It spans approximately 44 kb and yields multiple, extensively spliced RNA isoforms that are capped, polyadenylated, and tissue-specifically expressed, especially in the brain, thymus, testis, ovary, and uterus[1][2]. GHRLOS overlaps both the GHRL gene and a variant of the SEC13 gene, which may allow it to regulate transcription or translation of these genes through antisense mechanisms[1]. GHRLOS has no protein-coding potential and is highly divergent between species, suggesting rapid evolutionary change[1]. Functionally, GHRLOS is thought to play a regulatory role in the ghrelin axis and possibly other gene networks. Its expression is altered in colorectal cancer, where reduced GHRLOS levels are associated with metastasis and poor prognosis, indicating its potential utility as a disease biomarker[3]. However, its precise physiological roles and molecular mechanisms remain to be fully elucidated[1][2][3].

Other names
GHRLOSGHRL-AS1NCRNA00068non-protein coding RNA 68ghrelinOSGHRL antisense RNA 1 (non-protein coding)GHRLAS
02

Biological functions

Gene regulation (especially of ghrelin/GHRL)Possible regulation of neighboring genes (TATDN2, SEC13)RNA interference and transcriptional interferencePotential biomarker function
03

Disease associations

Cancer (particularly colorectal cancer, where decreased GHRLOS is associated with poor prognosis and metastasis)Other (potential broad roles in endocrine regulation, but not yet fully defined)
04

Biomarkers

GHRLOS expression levels (correlate with metastasis, prognosis in colorectal cancer)

Beyond the preview

Go deeper on Ghrelin antisense RNA 1 (non-protein coding) (GHRLOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ghrelin antisense RNA 1 (non-protein coding) (GHRLOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call